These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 20175824

  • 1. CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.
    Clarke LE, Frauenhoffer E, Fox E, Neves R, Bruggeman RD, Helm KF.
    J Cutan Pathol; 2010 Jul; 37(7):737-43. PubMed ID: 20175824
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL, DiMaio DJ.
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [Abstract] [Full Text] [Related]

  • 3. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
    Gleason BC, Calder KB, Cibull TL, Thomas AB, Billings SD, Morgan MB, Hiatt KM, Smoller BR.
    J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S, Mar N, McCalmont TH.
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [Abstract] [Full Text] [Related]

  • 5. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
    Kanner WA, Brill LB, Patterson JW, Wick MR.
    J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
    [Abstract] [Full Text] [Related]

  • 6. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
    Wieland CN, Dyck R, Weenig RH, Comfere NI.
    J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
    [Abstract] [Full Text] [Related]

  • 7. Atypical fibroxanthoma with keloidal collagen.
    Fussell JN, Cooke ER, Florentino F, Sheehan DJ.
    Am J Dermatopathol; 2010 Oct; 32(7):713-5. PubMed ID: 20700041
    [Abstract] [Full Text] [Related]

  • 8. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
    Buonaccorsi JN, Plaza JA.
    Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
    [Abstract] [Full Text] [Related]

  • 9. CD117 immunoreactivity in atypical fibroxanthoma.
    Mathew RA, Schlauder SM, Calder KB, Morgan MB.
    Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
    [Abstract] [Full Text] [Related]

  • 10. CD117 is not a useful marker for diagnosing atypical fibroxanthoma.
    Beer TW, Haig D.
    Am J Dermatopathol; 2009 Oct; 31(7):649-52. PubMed ID: 19652583
    [Abstract] [Full Text] [Related]

  • 11. Subcutaneous atypical fibrous histiocytoma.
    Garrido-Ruiz MC, Ramos P, Enguita AB, Rodriguez Peralto JL.
    Am J Dermatopathol; 2009 Jul; 31(5):499-501. PubMed ID: 19542931
    [Abstract] [Full Text] [Related]

  • 12. Melanoma simulating atypical fibroxanthoma.
    Sangüeza M, Zelger B.
    Am J Dermatopathol; 2007 Dec; 29(6):551-4. PubMed ID: 18032950
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Atypical fibrous histiocytoma and atypical fibroxanthoma: presentation of two cases.
    Kram A, Stańczyk J, Woyke S.
    Pol J Pathol; 2003 Dec; 54(4):267-71. PubMed ID: 14998296
    [Abstract] [Full Text] [Related]

  • 15. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
    Sakamoto A, Oda Y, Yamamoto H, Oshiro Y, Miyajima K, Itakura E, Tamiya S, Honda Y, Ishihara A, Iwamoto Y, Tsuneyoshi M.
    Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
    [Abstract] [Full Text] [Related]

  • 16. CD10, a useful marker for atypical fibroxanthomas.
    Weedon D, Williamson R, Mirza B.
    Am J Dermatopathol; 2005 Apr; 27(2):181. PubMed ID: 15798451
    [No Abstract] [Full Text] [Related]

  • 17. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
    Hanlon A, Stasko T, Christiansen D, Cyrus N, Galan A.
    Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
    [Abstract] [Full Text] [Related]

  • 18. Expression of the CD10 antigen (neutral endopeptidase) by mesenchymal tumors of the skin.
    Kanitakis J, Bourchany D, Claudy A.
    Anticancer Res; 2000 Mar; 20(5B):3539-44. PubMed ID: 11131659
    [Abstract] [Full Text] [Related]

  • 19. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin.
    Rizzardi C, Angiero F, Melato M.
    Anticancer Res; 2003 Mar; 23(2C):1847-51. PubMed ID: 12820468
    [Abstract] [Full Text] [Related]

  • 20. HMB-45 expression in a clear cell variant of atypical fibroxanthoma.
    Cai JP, Randall B.
    J Cutan Pathol; 2006 Feb; 33(2):186-8. PubMed ID: 16420318
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.